GSK Stockmann advised Target Global on the deal.The Berlin-based venture capital investor Target Global and another co-lead investor partecipated in the current financing round of the creators…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
